308 related articles for article (PubMed ID: 24820353)
21. Modifying factors and phenotypic diversity in Wilson's disease.
Lutsenko S
Ann N Y Acad Sci; 2014 May; 1315():56-63. PubMed ID: 24702697
[TBL] [Abstract][Full Text] [Related]
22. Repeated transplantation of hepatocytes prevents fulminant hepatitis in a rat model of Wilson's disease.
Sauer V; Siaj R; Stöppeler S; Bahde R; Spiegel HU; Köhler G; Zibert A; Schmidt HH
Liver Transpl; 2012 Feb; 18(2):248-59. PubMed ID: 22140056
[TBL] [Abstract][Full Text] [Related]
23. The Long-Evans Cinnamon rat: an animal model for Wilson's disease.
Terada K; Sugiyama T
Pediatr Int; 1999 Aug; 41(4):414-8. PubMed ID: 10453197
[TBL] [Abstract][Full Text] [Related]
24. Neurologic Wilson's disease.
Lorincz MT
Ann N Y Acad Sci; 2010 Jan; 1184():173-87. PubMed ID: 20146697
[TBL] [Abstract][Full Text] [Related]
25. Wilson's disease: a new gene and an animal model for an old disease.
Cuthbert JA
J Investig Med; 1995 Aug; 43(4):323-36. PubMed ID: 7552582
[TBL] [Abstract][Full Text] [Related]
26. Compound overload of copper and iron in patients with Wilson's disease.
Hayashi H; Yano M; Fujita Y; Wakusawa S
Med Mol Morphol; 2006 Sep; 39(3):121-6. PubMed ID: 16998622
[TBL] [Abstract][Full Text] [Related]
27. ATP7B gene therapy of autologous reprogrammed hepatocytes alleviates copper accumulation in a mouse model of Wilson's disease.
Cai H; Cheng X; Wang XP
Hepatology; 2022 Oct; 76(4):1046-1057. PubMed ID: 35340061
[TBL] [Abstract][Full Text] [Related]
28. Heterozygous tx mice have an increased sensitivity to copper loading: implications for Wilson's disease carriers.
Cheah DM; Deal YJ; Wright PF; Buck NE; Chow CW; Mercer JF; Allen KJ
Biometals; 2007 Oct; 20(5):751-7. PubMed ID: 17136311
[TBL] [Abstract][Full Text] [Related]
29. Positron emission tomography of copper metabolism in the Atp7b-/- knock-out mouse model of Wilson's disease.
Peng F; Lutsenko S; Sun X; Muzik O
Mol Imaging Biol; 2012 Feb; 14(1):70-8. PubMed ID: 21327972
[TBL] [Abstract][Full Text] [Related]
30. [Wilson's disease in paediatric age: diagnosis and treatment. Recent advances].
Palumbo E
Recenti Prog Med; 2008 Nov; 99(11):561-4. PubMed ID: 19209540
[TBL] [Abstract][Full Text] [Related]
31. Transplantation of ATP7B-transduced bone marrow mesenchymal stem cells decreases copper overload in rats.
Chen S; Shao C; Dong T; Chai H; Xiong X; Sun D; Zhang L; Yu Y; Wang P; Cheng F
PLoS One; 2014; 9(11):e111425. PubMed ID: 25375371
[TBL] [Abstract][Full Text] [Related]
32. Copper metabolism after living donor liver transplantation for hepatic failure of Wilson's disease from a gene mutated donor.
Kobayashi S; Ochiai T; Hori S; Suzuki T; Shimizu T; Gunji Y; Shimada H; Yamamoto S; Ogawa A; Kohno Y; Sunaga M; Shimazu M; Tanaka K
Hepatogastroenterology; 2001; 48(41):1259-61. PubMed ID: 11677941
[TBL] [Abstract][Full Text] [Related]
33. Dental considerations in the patient with Wilson's disease.
Lohe VK; Kadu RP; Degwekar SS; Bhowate RR; Wanjari AK; Dangore SB
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Jan; 111(1):20-3. PubMed ID: 21176821
[TBL] [Abstract][Full Text] [Related]
34. The potential of bone marrow stem cells to correct liver dysfunction in a mouse model of Wilson's disease.
Allen KJ; Cheah DM; Lee XL; Pettigrew-Buck NE; Vadolas J; Mercer JF; Ioannou PA; Williamson R
Cell Transplant; 2004; 13(7-8):765-73. PubMed ID: 15690978
[TBL] [Abstract][Full Text] [Related]
35. Imaging copper metabolism imbalance in Atp7b (-/-) knockout mouse model of Wilson's disease with PET-CT and orally administered 64CuCl2.
Peng F; Lutsenko S; Sun X; Muzik O
Mol Imaging Biol; 2012 Oct; 14(5):600-7. PubMed ID: 22170165
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic potential of hepatocyte-like-cells converted from stem cells from human exfoliated deciduous teeth in fulminant Wilson's disease.
Fujiyoshi J; Yamaza H; Sonoda S; Yuniartha R; Ihara K; Nonaka K; Taguchi T; Ohga S; Yamaza T
Sci Rep; 2019 Feb; 9(1):1535. PubMed ID: 30733544
[TBL] [Abstract][Full Text] [Related]
37. Tracing copper-thiomolybdate complexes in a prospective treatment for Wilson's disease.
Zhang L; Lichtmannegger J; Summer KH; Webb S; Pickering IJ; George GN
Biochemistry; 2009 Feb; 48(5):891-7. PubMed ID: 19146437
[TBL] [Abstract][Full Text] [Related]
38. [The onset of psychiatric disorders and Wilson's disease].
Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
[TBL] [Abstract][Full Text] [Related]
39. Wilson's disease: a comprehensive review of the molecular mechanisms.
Wu F; Wang J; Pu C; Qiao L; Jiang C
Int J Mol Sci; 2015 Mar; 16(3):6419-31. PubMed ID: 25803104
[TBL] [Abstract][Full Text] [Related]
40. A systems approach implicates nuclear receptor targeting in the Atp7b(-/-) mouse model of Wilson's disease.
Wilmarth PA; Short KK; Fiehn O; Lutsenko S; David LL; Burkhead JL
Metallomics; 2012 Jul; 4(7):660-8. PubMed ID: 22565294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
